search
drug regulators
Trends
- 1FDA Commissioner nominee Heidi Overton grilled over independence from Trump●If Heidi Overton is confirmed as FDA Commissioner, what will she do if Trump asks her to take an action she knows is wrong? When @SenatorHassan questioned her, Overton refused to even entertain the possibility that Trump could be wrong. When it comes t
Heidi Overton, President Trump's nominee for FDA Commissioner, faced questioning from Senator Maggie Hassan at her confirmation hearing. Hassan pressed her on whether she would refuse an unlawful or improper directive from Trump, but Overton declined to entertain the possibility that the president could be wrong, drawing criticism that she would not commit to independent decision-making at the agency that regulates drugs and medical products.
- 2Platform Trials Are Rewriting the Rules of Medical Evidence●Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up.
Platform trials, which test multiple treatments against a single control group, are changing how clinical evidence is generated in medicine. Commentators argue that regulators have not yet adapted their standards to this trial design, raising questions about how such evidence will be assessed for drug approvals.